BRIEF-Spectrum Pharmaceuticals Provides Update On Rolontis (Eflapegrastim) Pre-Approval Inspection

Reuters · 03/16/2021 11:26
BRIEF-Spectrum Pharmaceuticals Provides Update On Rolontis (Eflapegrastim) Pre-Approval Inspection

- Spectrum Pharmaceuticals Inc SPPI.O:

  • SPECTRUM PHARMACEUTICALS INC - FDA HAS SCHEDULED PRE-APPROVAL INSPECTION AT ROLONTIS® (EFLAPEGRASTIM) MANUFACTURING SITE IN MAY 2021

Source text for Eikon: ID:nBw9Rb7jxa

Further company coverage: SPPI.O


((Reuters.Briefs@thomsonreuters.com;))